Jeremy Jones, Ph.D., Postdoctoral Fellow, University of California, San Francisco
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
Harris WP, Mostaghel EA, Nelson PS, Montgomery B; Medscape. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol. 2009 Feb;6(2):76-85. PubMed PMID: 19198621. Androgen deprivation therapy remains a critical component of treatment for men with advanced prostate cancer, and data support ...
14-3-3η amplifies androgen receptor action at low DHT levels in vitro: Implications in prostate cancer
May 29, 2008: Mark Titus, Ph.D., Assistant Professor, Urologic Oncology, Roswell Park Cancer Institute
Targeting androgen/AR interactions in castration resistant prostate cancer: The case for secondary hormonal therapy
Charles J. Ryan, M.D., Assistant Clinical Professor, Medicine, Member, UCSF Comprehensive Cancer Center, University of California at San Francisco